Moore Kuehn Encourages MJCO, CBMG, SCBH, and INWK to Contact Law Firm

NEW YORK, Aug. 25, 2020

• Majesco (NASDAQ: MJCO)

A proxy was recently filed with the SEC regarding Thoma Bravo's acquisition of Majesco, which may omit material information regarding the financial metrics and analyses used to evaluate the merger.  Under the proposed transaction, shareholders of Majesco will receive $13.10 for every share owned.

• Cellular Biomedicine Group, Inc. (NASDAQ: CBMG)

Cellular Biomedicine has agreed to be acquired by consortium led by the company's CEO Bizuo Liu.  Under the proposed transaction, shareholders of Cellular Biomedicine will receive $19.75 for every share owned.

• InnerWorkings, Inc. (NASDAQ: INWK)

A proxy was recently filed with the SEC regarding HH Global's acquisition of InnerWorkings.  Upon completion of the merger, shareholders of InnerWorkings will receive $3.00 for every share owned.  The investigation concerns whether InnerWorkings' board of directors oversaw an unfair process and ultimately agreed to an inadequate deal price.

• Seacoast Commerce Banc Holdings (OTCPK: SCBH)

Seacoast Commerce has agreed to be acquired by Enterprise Financial Services.  Under the proposed transaction, shareholders of Seacoast will receive 0.5061 of a share of Enterprise common stock per Seacoast share owned.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.